Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Six engaging sessions focusing on Prevention of Kidney Diseases, Brain Stem Death Declaration, Deceased Donor Management, Prevention of Liver Diseases, Legal Aspects of Organ and Tissue Donation, Eye Donation and Corneal Transplant held as part of the Webinar
Subscribe To Our Newsletter & Stay Updated